[1] D. Schardt, T. Elsasser. Heavy-ion tumor therapy: Physical and radiobiological benefits. Reviews of modern physics, 82, (2010) 383–425. [2] H. Paganetti. Relating proton treatments to photon treatment via the relative biological effectiveness–should we revise current clinical practice. Int J Radiat oncol Bio phys, 91, (2015) 892–894. [3] G. Giovannini, T. Bohlen, G. Cabal, J. Bauer, T. Tessonnier, K. Frey, J. Debus, A. M airani, K. Parodi. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios. Radiation Oncology, (2016). [4] S. Jan, G. Santin, D. Strul, S. Staelens, D. Autret, et al., GATE: a simulation toolkit for PET and SPECT. Phys Med Biol, 49(19), (2004) 4543-4561. [5] D. E. Lea. Action of radiations on living cells: University Press. Combridge, (1946). [6] T. Sato, Y. Kase, R. Watanabe, K. Niita, L. Sihver. Biological Dose Estimation for Charged-Particle Therapy Using an Improved PHITS Code Coupled with a Microdosimetric Kinetic Model. Radiation Research, 171(1), (2009) 107-117. [7] A.F. Resch, G. Landry, F. Kamp, G. Cabal, C. Belka, J.J. Wilkens, K. Parodi, G. Dedes. Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization. Physica Medica, 36, (2017) 91-102. [8] J.J. Wilkens, U. Oelfke. A phenomenological model for the relative biological effectiveness in therapeutic proton beams. Phys Med Biol, 49(13), (2004) 2811-2825. [9] M. Belli, F. Cera, R. Cherubini, M. Dalla Vecchia, A.M.I. Haque, F. Ianzini, P. Tiveron. RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility. International Journal of Radiation Biology, 74(4), (1998) 501-509. [10] M. Folkard, K. M. Prise, B. Vojnovic, H. C. Newman, M. J. Roper, B. D. Michael. Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ions. International Journal of Radiation Biology, 69(6), (1996) 729-738. [11] M. Wedenberg, B. K. Lind, B. Hardemark. A model for the relative biological effectiveness of proton: the tissue specific parameter alpha/beta of photons is a predictor for the sensitivity to LET change. Acta Oncol, 52(3), (2013) 580-588. [12] A. Carabe-Fernandez, R.G. Dale, B. Jones. The incorporation of the concept of minimum RBE (RBE min) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments. International Journal of Radiation Biology, 83(1), (2007) 27-39. [13] A. L. McNamara, J. Schuemann, H. Paganetti. A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data. Phys Med Biol, 60(21), (2015) 8399-8416. [14] M. C. Joiner, A. van der Kogel. Basic Clinical Radiobiology, 4th Ed., (2009).